Figure 5. KIF12 deficiency resulted in upregulation of ACC1 and PC.
(A–D) ACC1 and PC immunofluorescence microscopy of Kif12mut/mut mouse liver cryosections (A) and HepG2 cells transduced with scrambled control (SC) and KIF12-knockdown (KD) vectors (B), with respective statistics (C and D). Scale bars, 100 μm in A and 20 µm in (B). Error bars, mean ± SEM. Welch’s t test. Biological replicates, 12 optical fields from 3 mice (C); and individual cells (D). (E, F) ACC1 immunoblotting of HepG2 cell lysates transduced with SC and KIF12-KD vectors (E) with statistics (F). Error bars, mean ± SEM. Welch’s t test. Biological replicates, individual dishes. (G) Comparison of CPT1 activity of wild type (WT) and Kif12mut/mut mouse livers, as an indicator of mitochondrial beta oxidation of fatty acids. Error bars, mean ± SEM. Unpaired single-sided Welch’s t test. Biological replicates, mouse individuals. (H) The working hypothesis. KIF12 deficiency may affect beta oxidation of the liver probably through the elevation of the ACC1 product, Malonyl-CoA, as well as upregulating lipid production, to promote steatosis. Corresponding to Fig. EV5.
